Filter on category

Downloads

filter

Nyxoah Q1 Report 2025

14 May 2025

Financial

Download (ENG) Download (FR)

Nyxoah Annual Report 2024

20 March 2025

Financial

Download (ENG PDF) Download (FR PDF) Download (FR ESEF preview) Download (FR ESEF) (.xbri)

Nyxoah Q3 Report 2024

6 November 2024

Financial

Download (ENG) Download (FR)

Nyxoah H1 Report 2024

6 August 2024

Financial

Download (ENG PDF) Download (FR PDF)

Nyxoah Q1 2024 Report

14 May 2024

Financial

Download (ENG) Download (FR)

Nyxoah Annual Report 2023

20 March 2024

Financial

Download (ENG PDF) Download (FR PDF) Download (FR ESEF zip) Download (FR ESEF)

Nyxoah Q3 2023 report

8 November 2023

Financial

Download (ENG) Download (FR)

Nyxoah H1 report 2023

8 August 2023

Financial

Download (ENG) Download (FR)

Nyxoah Q1 2023 report

16 May 2023

Financial

Download (ENG) Download (FR)

Nyxoah Annual Report 2022

22 March 2023

Financial

Download (ENG PDF) Download (FR ESEF) Download (FR PDF) Download (FR ESEF zip)

All rights reserved © 2021 Nyxoah SA. All content on this presentation, including the texts, trademarks, service marks, logos, illustrations, photos, graphics, design etc., are the property of Nyxoah SA. Nyxoah SA. owns all rights with respect to any of their trademarks, service marks, logos, and copyrighted works appearing on this presentation. Patented and design protected technology. Device not for sale in U.S. The Genio^® system by Nyxoah is intended to be used for patients who suffer from moderate to severe Obstructive Sleep Apnea (AHI of 15 to 65), have not tolerated, failed or refused PAP therapy and are not significantly overweight. Reviewed and approved: February 2020

Cookie Settings